WMSA
CTIC

Weiss Multi-Strategy Advisers’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,110
Closed -$208K – 1120
2014
Q1 		$208K Buy
+6,110
New +$209K ﹤0.01% 909

Other funds holding CTIC

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Weiss Multi-Strategy Advisers's CTIC Position: Q2 2014 in Review

Weiss Multi-Strategy Advisers sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2014, closing a stake of 6,110 shares — an estimated $208K sold.

Weiss Multi-Strategy Advisers first reported a position in CTIC in Q1 2014 and held it in 1 quarter. The position peaked at $208K in Q1 2014. 89 funds tracked by Wall St. Rank hold CTIC as of Q2 2014.

  • Weiss Multi-Strategy Advisers reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 6,110 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2014, an estimated $208K.
  • Weiss Multi-Strategy Advisers first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2014 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's CTI BioPharma Corp. (DE) Common Stock position peaked at $208K in Q1 2014.
  • 89 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.